NasdaqGM:VRNAPharmaceuticals
Is There Still Opportunity in Verona Pharma After Ohtuvayre Approval and 246% Price Surge?
If you have been watching Verona Pharma’s stock lately, you are probably wondering what to do next. With shares closing at $106.82 in the latest session, it is clear this is a company that has caught serious attention. Just look at the numbers, and you will see why: Verona Pharma is up 121.6% so far this year, and an eye-popping 246.7% over the past twelve months. But the real story goes further back, with staggering multi-year gains. Over the last three years, the stock has jumped 926.1%,...